BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37717992)

  • 1. Structure and functions of the N-terminal domain of steroid hormone receptors.
    Kumar R
    Vitam Horm; 2023; 123():399-416. PubMed ID: 37717992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryo-EM technique and its application: Structure of steroid hormone receptors.
    Kumar R
    Vitam Horm; 2023; 123():385-397. PubMed ID: 37717991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting steroid hormone receptor pathways in the treatment of hormone dependent cancers.
    Ko YJ; Balk SP
    Curr Pharm Biotechnol; 2004 Oct; 5(5):459-70. PubMed ID: 15544494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting.
    Kumar R
    Asian J Androl; 2016; 18(5):682-6. PubMed ID: 27364545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of conformational dynamics and flexibilities in the steroid receptor-coregulator protein complex formation.
    Kumar R
    Gen Comp Endocrinol; 2021 Aug; 309():113780. PubMed ID: 33882296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors.
    Hilser VJ; Thompson EB
    J Biol Chem; 2011 Nov; 286(46):39675-82. PubMed ID: 21937423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.
    Kumar R; McEwan IJ
    Endocr Rev; 2012 Apr; 33(2):271-99. PubMed ID: 22433123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges.
    Simons SS; Edwards DP; Kumar R
    Mol Endocrinol; 2014 Feb; 28(2):173-82. PubMed ID: 24284822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone receptors: an update.
    Beato M; Klug J
    Hum Reprod Update; 2000; 6(3):225-36. PubMed ID: 10874567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting steroid hormone receptors for anti-cancer therapy-A review on small molecules and nanotherapeutic approaches.
    Mahadik N; Bhattacharya D; Padmanabhan A; Sakhare K; Narayan KP; Banerjee R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1755. PubMed ID: 34541822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between allostery and intrinsic disorder in an ensemble.
    Motlagh HN; Li J; Thompson EB; Hilser VJ
    Biochem Soc Trans; 2012 Oct; 40(5):975-80. PubMed ID: 22988850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid hormone rapid signaling: the pivotal role of S-palmitoylation.
    Marino M; Ascenzi P
    IUBMB Life; 2006 Dec; 58(12):716-9. PubMed ID: 17424910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid hormone receptors in cancer development: a target for cancer therapeutics.
    Ahmad N; Kumar R
    Cancer Lett; 2011 Jan; 300(1):1-9. PubMed ID: 20926181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of steroid hormone receptor activity.
    Stanisić V; Lonard DM; O'Malley BW
    Prog Brain Res; 2010; 181():153-76. PubMed ID: 20478437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors.
    Ramamoorthy S; Nawaz Z
    Nucl Recept Signal; 2008 Apr; 6():e006. PubMed ID: 18432313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroids and endocrine disruptors--History, recent state of art and open questions.
    Hampl R; Kubátová J; Stárka L
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):217-23. PubMed ID: 24816231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid hormone receptor signaling in cancer.
    Cheng S; Balk SP
    Cancer Treat Res; 2003; 115():293-318. PubMed ID: 12613202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable steroid receptor responses: Intrinsically disordered AF1 is the key.
    Simons SS; Kumar R
    Mol Cell Endocrinol; 2013 Aug; 376(1-2):81-4. PubMed ID: 23792173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
    Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
    Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain.
    Kumar R; Litwack G
    Steroids; 2009 Nov; 74(12):877-83. PubMed ID: 19666041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.